Cellular senescence in liver diseases: From mechanisms to therapies
International Immunopharmacology · 2023-08 · 121 · 110522
DOI: 10.1016/j.intimp.2023.110522 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023-08. Verfasst von Ting Ge und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nantong University, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease, Liver Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 175 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Research of Jiangsu Higher Education Institutions of China, Jiangsu Commission of Health.
Abstract (Originalsprache)
Cellular senescence is an irreversible state of cell cycle arrest, characterized by a gradual decline in cell proliferation, differentiation, and biological functions. Cellular senescence is double-edged for that it can provoke organ repair and regeneration in physiological conditions but contribute to organ and tissue dysfunction and prime multiple chronic diseases in pathological conditions. The liver has a strong regenerative capacity, where cellular senescence and regeneration are closely involved. Herein, this review firstly introduces the morphological manifestations of senescent cells, the major regulators (p53, p21, and p16), and the core pathophysiologic mechanisms underlying senescence process, and then specifically generalizes the role and interventions of cellular senescence in multiple liver diseases, including alcoholic liver disease, nonalcoholic fatty liver disease, liver fibrosis, and hepatocellular carcinoma. In conclusion, this review focuses on interpreting the importance of cellular senescence in liver diseases and summarizes potential senescence-related regulatory targets, aiming to provide new insights for further researches on cellular senescence regulation and therapeutic developments for liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Nantong University, Nantong, Jiangsu, China.
- School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, China. Electronic address: xwx8991@163.com.
- School of Pharmacy, Nantong University, Nantong, Jiangsu, China. Electronic address: ntdxlcf@ntu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Research of Jiangsu Higher Education Institutions of China
- Jiangsu Commission of Health
Zitieren
APA
Ge, T., Shao, Y., Bao, X., Xu, W., & Lu, C. (2023). Cellular senescence in liver diseases: From mechanisms to therapies. International Immunopharmacology, 121, 110522. https://doi.org/10.1016/j.intimp.2023.110522
Vancouver
Ge T, Shao Y, Bao X, Xu W, Lu C. Cellular senescence in liver diseases: From mechanisms to therapies. International Immunopharmacology. 2023;121:110522. doi:10.1016/j.intimp.2023.110522
BibTeX
@article{Ge2023,
author = {Ge, Ting and Shao, Yunyun and Bao, Xiaofeng and Xu, Wenxuan and Lu, Chunfeng},
title = {Cellular senescence in liver diseases: From mechanisms to therapies},
journal = {International Immunopharmacology},
year = {2023},
volume = {121},
pages = {110522},
doi = {10.1016/j.intimp.2023.110522}
}
EUVIMED